Last year, Belgium’s ExeVir Bio raised 23 million euros ($27 million) to finance development of llama antibodies – and now it is ready to begin clinical development of a potential treatment ...
ImmunoPrecise provides a range of services that includes antibody discovery in wild-type and transgenic mouse, rat and chicken models, rabbit and llama monoclonal antibodies (mAbs), and custom and ...